Internet Archive Scholar

Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551

T. Min, L. Wali, D.M. Williams, E. Plummer, A. Gurung, J.W. Stephens
2017 Current Medical Research and Opinion  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (336.8 kB)
https://web.archive.org/web/20190429055722/https://cronfa.swan.ac.uk/Record/cronfa34694/Download/0034694-16082017153748.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

doi:10.1080/03007995.2017.1336432 pmid:28562098 fatcat:at2rgdfzkbc6fmywzfroopo54a
Citation

T. Min, L. Wali, D.M. Williams, E. Plummer, A. Gurung, J.W. Stephens. "Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551." Current Medical Research and Opinion 33.9 (2017) 1715-1716